Evidence map›Paper›PMID 30348234›Full record

ArticlePsychological medicine2019

Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study.

Eugenia Kravariti, Arsime Demjaha, Jolanta Zanelli, Fowzia Ibrahim, Catherine Wise, James H MacCabe, Abraham Reichenberg, Izabela Pilecka, Kevin Morgan, Paul Fearon and 8 more

Abstract read
In one paragraph

Article in Psychological medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. An etiological approach to psychosis: potential benefits for treatment, research and prevention.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  4. Article
  5. Are cognitive deficits more severe among people with treatment-resistant schizophrenia than treatment responders?Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy.European archives of psychiatry and clinical neuroscience · 2024
    Article
  10. The tertiary service for psychosis: Holistic recommendations for people with complex psychosis.Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Eugenia KravaritiPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Arsime DemjahaPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Jolanta ZanelliPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Fowzia IbrahimAcademic Rheumatology Department, School of Immunology & Microbial Sciences, King's College London, Weston Education Centre, 10 Cutcombe Road, London SE5 9RJ, England, UK.
Catherine WisePsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
James H MacCabePsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Abraham ReichenbergPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Izabela PileckaPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Kevin MorganDepartment of Psychology, University of Westminster, 115 New Cavendish Street, London W1W 2UW, England, UK.
Paul FearonDepartment of Psychiatry, St. Patricks University Hospital and Trinity College, University of Dublin, James St., Dublin 8, Ireland.
Craig MorganHealth Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Gillian A DoodyDivision of Psychiatry and Applied Psychology, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, England, UK.
Kim DonoghueAddictions Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Peter B JonesDepartment of Psychiatry, University of Cambridge, Herchel Smith Building, Cambridge CB2 0SZ, England, UK.
Anil Şafak KaçarKoç University, School of Medicine, Rumelifeneri Yolu 34450 Sarıyer, Istanbul, Turkey.
Paola DazzanPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Julia LappinPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.
Robin M MurrayPsychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, England, UK.

Funding

Department of HealthMedical Research Council G0500817Medical Research Council MR/L011794/1MRF_ C0439Wellcome TrustWellcome Trust HEALTH-F2-2009-241909Wellcome Trust WT087417
6 · The paper itself

Abstract

backgroundNeuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the first-episode of TR psychosis.

methodsWe report baseline neuropsychological findings from a longitudinal, population-based study of first-episode psychosis, which followed up cases from index admission to 10 years. At the 10-year follow up patients were classified as treatment responsive or TR after reconstructing their entire case histories. Of 145 cases with neuropsychological data at baseline, 113 were classified as treatment responsive, and 32 as TR at the 10-year follow-up.

resultsCompared with 257 community controls, both case groups showed baseline deficits in three composite neuropsychological scores, derived from principal component analysis: verbal intelligence and fluency, visuospatial ability and executive function, and verbal memory and learning (p values⩽0.001). Compared with treatment responders, TR cases showed deficits in verbal intelligence and fluency, both in the extended psychosis sample (t = -2.32; p = 0.022) and in the schizophrenia diagnostic subgroup (t = -2.49; p = 0.017). Similar relative deficits in the TR cases emerged in sub-/sensitivity analyses excluding patients with delayed-onset treatment resistance (p values<0.01-0.001) and those born outside the UK (p values<0.05).

conclusionsVerbal intelligence and fluency are impaired in patients with TR psychosis compared with those who respond to treatment. This differential is already detectable - at a group level - at the first illness episode, supporting the conceptualisation of TR psychosis as a severe, pathogenically distinct variant, embedded in aberrant neurodevelopmental processes.

Indexed as

Drug ResistanceAdolescentAdultCross-Sectional StudiesExecutive FunctionFemaleFollow-Up StudiesHumansIntelligenceLinear ModelsMaleMiddle AgedNeuropsychological TestsPsychotic DisordersSchizophreniaSpatial MemoryCohort studyfirst episodeneuropsychologicalpopulation-basedpsychosisschizophreniatreatment resistant

Identifiers

PMID30348234
PMCPMC6712950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.